Zusammenfassung
Die fokale Laserkoagulation bilateraler Drusen zur Prophylaxe einer schweren Sehbehinderung durch fortgeschrittene altersbedingte Makuladegeneration ist ein neues therapeutisches Konzept, das auf seine Wirksamkeit und Sicherheit im Langzeitverlauf überprüft werden muss. Zu diesem Zweck wurde in einer Pilotstudie ein homogenes Kollektiv von zehn konsekutiven Patienten an einem Auge standardisiert behandelt. Die Partneraugen fungierten als Kontrollgruppe. Nach einer medianen Nachbeobachtungsdauer von 3,9 Jahren wies die Behandlungsgruppe im Bezug zur Kontrollgruppe eine um 0,6 Zeilen geringere Visusreduktion (p = 0,2) und eine signifikante Reduktion der Drusenfläche (p = 0,04) auf. 77,8% der behandelten Augen hatten sichtbare Zeichen einer Drusenresorption. In der Behandlungsgruppe entwickelte kein Auge eine Komplikation im Sinne einer atrophen oder neovaskulären Makulopathie. Im Gegensatz dazu entstand in einem (11,1%) von 9 Augen der Kontrollgruppe eine choroidale Neovaskularisation. Die hier vorliegenden Ergebnisse belegen die potentielle Wirksamkeit und nachhaltende Sicherheit der fokalen Laserkoagulation von bilateralen Drusen in Rahmen der altersbedingten Makuladegeneration.
Summary
The prophylactic laser treatment of bilateral early age-related macular degeneration induces accelerated regression of macular drusen. To assess the therapeutic effect on retinal morphology and visual function, we conducted a pilot study with 20 eyes of 10 consecutive patients. The median time of follow-up was 3,9 years. In comparison to the untreated partner-eyes, the treated eyes showed a, although insignificant, minor loss of visual acuity of 1,4 versus 0,8 lines on the ETDRS-chart. Regression of drusen area was significantly greater in the treatment group (p = 0,04). 77,8% of the treated eyes demonstrated at least some resorption of Drusen. Drusen that did not respond, showed either massive confluence or pronounced flattening. None of the treated eyes developed either choroidal neovascularization (CNV) or atrophy. On the contrary, one eye (11,1%) in the control group developed CNV. The results of this pilot trial suggest the beneficial effect and a long-term safety of the focal laser treatment of bilateral drusen in age-related macular degeneration.
Similar content being viewed by others
Literatur
Apple DJ, Goldberg MF, Wyhinny G (1973) Histopathology and ultrastructure of the argon laser in human retinal and choroidal vasculatures. Am J Ophthalmol 75: 595–609
Bailey IL, Lovie JE (1976) New design principles for visual acuity letter chart. Am J Optom Physiol Opt 53: 740–745
Bressler NM, Bressler SB, Seddon JM, Gragoudas ES, Jacobson LP (1988) Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina 8: 109–114
Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR (1989) The grading and the prevalence of macular degeneration in the Chesapeake Bay watermen. Arch Ophthalmol 107: 847–852
Bressler NM, Munoz B, Maguire MG, Vitale SE, Schein OD, Taylor HR, West SK (1995) Five-year incidence and disappearance of drusen and retinal pigment abnormalities. Arch Ophthalmol 113: 301–308
Bressler SB, Maguire MG, Bressler NM, Fine SL (1990) The Macular Photocoagulation Study Goup. Relationship of Drusen and abnormalities of the retinale pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 108: 1442–1447
Duvall J, Tso MOM (1985) Cellular mechanisms of resolution of drusen after laser coagulation. Arch Ophthalmol 103: 694–703
Ferris FL, Kassof A, Bresnick GH, Bailey IL (1982) New visual acuity charts for clinical research. Am J Ophthalmol 94: 91–96
Figueroa MS, Regueras A, Bertrand J (1994) Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina 14: 391–396
Fisher RF (1987) The influence of age on some ocular basement membranes. Eye 1: 184–189
Frennesson IC, Nilsson SEG (1995) Effekt of argon (green) laser treatment of soft drusen in early age-related maculopathy: A 6 month prospective study. Br J Ophthalmol 79: 905–909
Gass JDM (1973) Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 90: 206–217
Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, Chisholm ICH, Bird AC (1994) Bilateral macular drusen in age-related macular degeneration. Ophthalmology 101: 1522–1528
Kini MM, Leibowitz HM, Colton TL, Nickerson RJ, Ganley JP, Dawber TR (1978) Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham Eye study. Am J Ophthalmol 85: 28–34
Leibowitz H, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, Nickerson RJ, Pool J, Colton TL, Ganley JP, Loewenstein JI, Dawber TR (1980) The Framingham Eye Study Monograph; an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1977. Surv Ophthalmol 24 [Suppl]: 335–610
Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY (1993) The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 111: 831–836
Macular Photocoagulation Study Group (1993) Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111: 1189–1199
Marshall J (1987) The ageing retina: physiology or pathology. Eye 1: 282–295
Marshall J, Mellerio J (1970) Laser irradiation of retinal tissue. Br Med Bull 26: 156–160
Pauleikhoff D, Barondes MJ, Minassian D, Chisholm ICH, Bird AC (1990) Drusen as risk factors in age related macular disease. Am J Ophthalmol 109: 38
Sarks SH (1976) Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol 60: 324
Sarks SH (1982) Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust N Z J Ophthalmol 10: 91–97
Sarks SH (1980) Drusen and their relationship to senile macular degeneration. Aust N Z J Ophthalmol 8: 117–130
Sigelman J (1991) Foveal drusen resorbtion one year after perfoveal laser photocoagulation. Ophthalmology 98: 1379–1383
Smiddy WE, Fine SL (1984) Prognosis of patients with bilateral macular drusen. Ophthalmology 91: 271–277
Smiddy WE, Fine SL, Quigley HA, Dunkelberge G, Hohmann RM, Addicks EM (1986) Cell proliferation after laser photocoagulation in primate retina. Arch Ophthalmol 104: 1065–1069
The International Age-Related Maculopathy Study Group (1995) An international classification system for ARM. Surv Ophthalmol 39: 367
The Wisconsin Age-Related Maculopathy Grading System (1991) Available from: National Technical Information Service (Accession No. PB91-184267)
Wallow IHL, Tso MOM (1973) Repair after xenon arc photocoagulation: II. A clinical and light microscopic study of the evolution of retinal lesions in the rhesus monkey. Am J Ophthalmol 75: 610–625
Wetzig PC (1988) Treatment of drusen-related aging macular degeneration by photocoagulation. Trans Am Ophthalmol Soc 86: 276–290
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tittl, M., Maar, N. & Stur, M. Langzeiteffekt und Sicherheit der fokalen Laserkoagulation bilateraler Drusen bei altersbedingter Makuladegeneration. Spektrum Augeheilkd 13, 202–207 (1999). https://doi.org/10.1007/BF03162762
Issue Date:
DOI: https://doi.org/10.1007/BF03162762